Merus (MRUS) CEO Lundberg received 300,000 Share Option (right to buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Sven Ante Lundberg (President, CEO & PEO at Merus N.V., MRUS) reported that they received 300,000 Share Option (right to buy) on Jan 29, 2025.
- Reporting person
- Lundberg Sven Ante
- Role
- President, CEO & PEO
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 29, 2025 | Grant or award (A) | Share Option (right to buy)On 300,000 Common Shares1 | +300,000 | - | - | 300,000 direct |
Holdings before and after
- Share Option (right to buy): 0 to 300,000 direct
Footnotes from the filing
- 1. Options vest over a four-year period from January 1, 2025. 25% vest on January 1, 2026 and in 36 equal monthly installments thereafter.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Lundberg report in this MRUS Form 4?
Sven Ante Lundberg (President, CEO & PEO at Merus N.V., MRUS) reported that they received 300,000 Share Option (right to buy) on Jan 29, 2025.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for MRUS
Earlier insider filings at MRUS
- Jan 31, 2025SEC Form 4 filed by Chief Financial Officer & PFO Perry Gregory D
- Jan 31, 2025SEC Form 4 filed by Chief Medical Officer Zohren Fabian
- Aug 22, 2024VP Controller, PAO Shuman Harry converted options into 5,000 shares and sold $270,000 worth of shares (5,000 units at $54.00) (SEC Form 4)
- Jul 3, 2024SEC Form 4 filed by Chief Medical Officer Zohren Fabian
- Jun 28, 2024COO & GC Silverman Peter B. exercised 10,000 shares at a strike of $17.94 and sold $600,000 worth of shares (10,000 units at $60.00) (SEC Form 4)
Quantisnow market dataNASDAQ
MRUS
Merus N.V.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2016
Get push alerts for MRUS
Full MRUS profile on Quantisnow Follow MRUS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time